EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study anti-viral drugs for their efficiency against multiple SARS CoV-2 drug targets within molecular docking, molecular quantum similarity, and chemical reactivity indices frameworks

Alejandro Morales-Bayuelo iD, Jesús Sánchez-Márquez, Ricardo Vivas-Reyes iD, Savaş Kaya

F1000Research · 2024

DOI: 10.12688/f1000research.146350.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, 2024. Verfasst von Alejandro Morales-Bayuelo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Universidad del Sinú, Grupo GENOMA, Cartagena, Bolivar, 36987, Colombia. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation, SARS-CoV-2, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unisinu 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study focused on drug discovery for COVID-19, emphasizing the challenges posed by the pandemic and the importance of understanding the virus’s biology. The research utilized molecular docking and quantum similarity analyses to explore potential ligands for SARS-CoV-2 RNA-dependent RNA polymerase. Docking Results Docking outcomes for various ligands, including Oseltamivir, Prochloraz, Valacyclovir, Baricitinib, Molnupiravir, Penciclovir, Famciclovir, Lamivudine, and Nitazoxanide, were presented. Interactions between ligands and specific residues in the RNA-dependent RNA polymerase were analyzed. Reactivity Descriptors Global parameters, such as electronic chemical potential, chemical hardness, global softness, and global electrophilicity, were computed for the ligands. For the local reactivity descriptors, the Fukui Functions were used. Fukui functions, representing electrophilic and nucleophilic sites, were calculated for selected ligands (Valacyclovir and Penciclovir). Nucleophilic character assignments for specific molecular regions were discussed, providing insights into potential charge-donating interactions. Results and Discussion Challenges in COVID-19 drug discovery, such as virus mutability, rapid evolution, and resource limitations, were summarized. Progress in vaccine development and the need for ongoing research to address variants and breakthrough cases were emphasized. Overlap Operator Analysis Higher MQSM between Lamivudine and Molnupiravir (0.5742) indicates structural and electronic similarity. Lowest MQSM between Oseltamivir and Prochloraz (0.2233) implies structural dissimilarity. Coulomb Operator Analysis Higher MQSM between Lamivudine and Molnupiravir (0.9178) suggests both structural and electronic similarity. Lowest MQSM between Baricitinib and Famciclovir (0.6001) indicates greater structural diversity. Measurements above 0.5 in Table 3 suggest electronic similarity, emphasizing the electronic aspects in molecular analysis. In this sense, it study employed a multi-faceted approach combining molecular docking, quantum similarity analyses, and chemical reactivity assessments to explore potential drug candidates for COVID-19. The findings provide valuable insights into ligand interactions, reactivity patterns, and the challenges associated with drug discovery in the context of the global pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMolecular Docking SimulationSARS-CoV-2COVID-19 Drug TreatmentHumansLigandsQuantum TheoryRNA-Dependent RNA PolymeraseDrug DiscoveryCOVID-19

Stichwörter der Autor:innen

COVID-19 treatmentsDensity Functional Theory.SARS-CoV-2 viruschemical reactivity indicesmolecular dockingmolecular quantum similarity

Substanzen

Antiviral AgentsLigandsRNA-Dependent RNA Polymerase

Autor:innen und Institutionen

  • Universidad del Sinú, Grupo GENOMA, Cartagena, Bolivar, 36987, Colombia.
  • Departamento de Química-Física, Universidad de Cadiz, Cádiz, Andalusia, 544578, Spain.
  • Group of Quantum and Theoretical Chemistry, Faculty of Exacts and Naturals Sciences, University of Cartagena, Bolívar, Colombia.
  • Faculty of Science Department of Chemistry, Sivas Cumhuriyet University, Sivas, 58140, Turkey.

ORCID-Profile: Alejandro Morales-Bayuelo, Ricardo Vivas-Reyes

Förderung

  • Unisinu 2024

Zitieren

APA

Morales-Bayuelo, A., Sánchez-Márquez, J., Vivas-Reyes, R., & Kaya, S. (2024). Study anti-viral drugs for their efficiency against multiple SARS CoV-2 drug targets within molecular docking, molecular quantum similarity, and chemical reactivity indices frameworks. F1000Research. https://doi.org/10.12688/f1000research.146350.2

Vancouver

Morales-Bayuelo A, Sánchez-Márquez J, Vivas-Reyes R, Kaya S. Study anti-viral drugs for their efficiency against multiple SARS CoV-2 drug targets within molecular docking, molecular quantum similarity, and chemical reactivity indices frameworks. F1000Research. 2024. doi:10.12688/f1000research.146350.2

BibTeX
@article{MoralesBayuelo2024,
  author = {Morales-Bayuelo, Alejandro and Sánchez-Márquez, Jesús and Vivas-Reyes, Ricardo and Kaya, Savaş},
  title = {Study anti-viral drugs for their efficiency against multiple SARS CoV-2 drug targets within molecular docking, molecular quantum similarity, and chemical reactivity indices frameworks},
  journal = {F1000Research},
  year = {2024},
  doi = {10.12688/f1000research.146350.2}
}
Kostenlos starten →